Sen. Saud Anwar

Maddy summaryThis bill requires Connecticut public schools to start no earlier than 8:30 a.m. for students in grades six through twelve. It directly affects middle and high schools, students in those grades, and school districts across the state. The law mandates collaboration between the Departments of Education and Public Health with school boards to implement the new start times, provide resources, and address challenges like transportation logistics. The policy change aims to align school schedules with health recommendations for adolescent sleep patterns.

Maddy summarySB 728 would require Connecticut school districts to treat student absences for observing cultural or religious holidays as excused absences. This directly affects students and families who observe such holidays, ensuring absences for these reasons do not count against attendance records. The bill mandates that school districts consider these absences excused under existing attendance policies, without specifying particular holidays or requiring new administrative procedures. It aims to align school attendance rules with the needs of diverse student communities.

Maddy summarySB 729 restores previous staff-to-child ratios and group size limits for child care centers and removes restrictions on family child care homes providing infant and toddler care. It requires the Office of Early Childhood to collaborate with the Department of Public Health before changing regulations and mandates annual reports on site visits, complaints, deaths, and serious injuries. The bill also prioritizes funding for child care providers and families. These changes aim to strengthen regulatory oversight and protections in early childhood care.

Maddy summarySB 727 requires schools built between 1948 and 1979 to test for polychlorinated biphenyls (PCBs), a chemical linked to health risks. It directly affects local school boards and regional education authorities in those buildings. The bill establishes a PCB Testing and Remediation Fund to provide financial assistance through grants or low-interest loans for testing and cleanup efforts. The stated purpose is to promote safety in school environments by addressing potential PCB contamination.

Maddy summarySB 758 prohibits pharmacy benefits managers (PBMs) from charging post-transaction fees or reclaiming payments from pharmacies after prescriptions are filled. It requires PBMs to pass drug manufacturer rebates directly to patients at the pharmacy counter and bans fees for formulary placement or tier access. The bill also decouples PBM compensation from drug costs and mandates transparency for group purchasing organizations contracting with PBMs. Pharmacies and patients directly benefit from these changes, while the Attorney General will oversee compliance to ensure rebate transparency and prevent cost-shifting.

Maddy summarySB 762 would require a plaintiff who rejects a defendant's settlement offer (filed within 18 months of the case's return date) to pay the defendant's attorney fees and litigation costs if the plaintiff later fails to recover more than the offered amount. This applies directly to individuals or entities initiating civil lawsuits who decline settlement proposals. The bill mandates that plaintiffs provide a bond or financial guarantee to cover these costs when rejecting such offers, aiming to discourage unnecessary litigation. Its purpose is to promote efficient dispute resolution by clarifying financial consequences for rejecting reasonable settlement terms. (SB 762, 2025 January Session)

Maddy summarySB 754 modifies housing laws to increase housing options and tenant protections. It requires municipalities to approve accessory apartments (like in-law units) on a case-by-case basis if they opt out of allowing them by default, and mandates zoning rules that allow converting vacant commercial buildings into residential or mixed-use spaces. The bill also creates a process for tenants to seal certain eviction records and prevents credit agencies from sharing these sealed records. Additionally, it establishes a Fair Housing Office to promote equitable housing access and implements a foreclosure mediation program to help homeowners avoid losing their homes. These changes directly affect municipalities, property owners, tenants, and homeowners statewide.

Maddy summarySB 767 authorizes Connecticut's Attorney General to seek court-appointed receivers to stabilize hospitals facing financial distress or operational crises, ensuring continued healthcare access. It grants the state the power to use eminent domain to take control of hospital facilities at risk of closure due to financial instability. The bill directly affects hospitals in crisis, requiring them to maintain operations, comply with regulations, and preserve patient services. Its key mechanism is the court process for receiver appointment and state takeover authority, aimed at preventing abrupt service interruptions. The bill's purpose is to ensure healthcare continuity and enable long-term solutions for struggling hospitals.

Maddy summarySB 766 permits the Office of the Child Advocate and Connecticut's Infant Mortality Review Committee (within the Department of Public Health) to share relevant information while following strict privacy rules. This bill directly affects these two state offices by enabling them to exchange data about infant mortality cases. The key provision removes barriers to sharing confidential information, allowing the committee to better analyze trends and risk factors in infant deaths. The goal is to improve the committee's ability to identify causes and develop effective strategies to reduce infant mortality rates in Connecticut.

Maddy summarySB 749 would reclassify xylazine - a veterinary sedative commonly mixed into illicit drugs like fentanyl - as a Schedule IV controlled substance under Connecticut law. This change would make it illegal to possess or distribute xylazine without authorization, directly affecting individuals who use or traffic the substance and law enforcement agencies. The bill’s key mechanism requires the Commissioner of Consumer Protection to formally list xylazine in Schedule IV, aligning state law with federal scheduling practices for similar substances. The purpose is to address public health concerns about xylazine’s misuse as an adulterant in opioids, without altering existing penalties for other controlled substances.